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Introduction
Psychiatric disorders are often associated with primary
headaches, both migraine and tension-type headaches.
Although the relationship between psychological factors
and headache still has to be further elucidated [1, 2], psy-
chological distress is certainly present in headache
patients suffering from chronic daily attacks [3].
Psychiatric disorders have also been described in patients
with episodic forms of primary headache, such as
migraine without aura (MO) and migraine with aura
(MA). To the best of our knowledge, no studies reported a
correlation between pain location and psychopathological
features in migraineurs. From a neurobiological perspec-
tive, a correlation between psychiatric symptoms, i.e.,
anxiety and depression, and laterality of vascular brain
lesions (mainly involving left cerebral hemisphere) has
been shown in previous studies [4]. Also, in depressed
patients hypoactivity of the left frontal cerebral regions
due to metabolic dysregulation has been evidenced by
functional neuroimaging studies [5]. Given that a cerebral
metabolic dysregulation is reported in migraine too [6], it
is possible that a metabolic imbalance in migraine patients
with left strictly unilateral attacks is likely related to a
higher expression of these psychopathological conditions.
Therefore, the present study was aimed at investigating
depression, anxiety and alexithymia in a population of
unilateral MO and/or MA patients with side-locked and
side-shifting pain during attacks.
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Abstract To explore the relation-
ship between the side of pain
during attacks and psychopatho-
logical features in strictly unilat-
eral migraine, we recruited 35
patients affected by migraine with
and/or without aura diagnosed
according to the revised ICHD-II
criteria. Seventeen patients had
right side-locked pain (R-SUM),
11 had left side-locked (L-SUM)
and 7 had side-shifting pain
(SSM). Patients were adminis-
tered the Hamilton Anxiety Scale,
the State and Trait Anxiety
Inventory-State Anxiety, the Beck
Depression Inventory and the 20-
item Toronto Alexithymia Scale.
Statistical analyses showed that
the L-SUM group was significant-
ly more anxious and depressed
than the other two groups of
patients. Our preliminary data
suggest that strictly left unilateral
migraine is associated with more
severe anxiety and depression.
This finding appears to be consis-
tent with studies that reported a
higher degree of these disorders
in patients with left cerebral
hemispheric damage.
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Materials and methods
Thirty-five patients affected by side-locked or side-shifting uni-
lateral MO and/or MA participated in the study (28 women and 7
men). Side-locked unilateral migraine (SLM) was defined
according to the presence of the pain on the same side of the head
during the attack, whereas in side-shifting unilateral migraine
(SSM) attacks the pain shifted from side to side during attack.
Mean age of the patients at the time of observation was
38.02±9.26 years (range: 20–56) [39.07±8.94 (range: 20–56) in
females, n=28; 33.85±10.04 (range: 22–51) in males, n=7].
Thirty patients were affected by MO (24 females and 6 males), 2
by MA (1 female and 1 male) and 3 by both MO and MA (all
females). Diagnosis was made according to the revised ICHD-II
criteria [7]. Mean age at onset of the disease was 19.34±7.70
(range: 7–34) [19.96±7.63 (range: 7–34) in females; 16.85±8.07
(range: 8–30) in males]. During attacks the pain was right side-
locked in 17 patients (13 F and 4 M), left side-locked in 11
patients (9 F and 2 M) and side-shifting in 7 patients (6 F and 1
M). The attack frequency over the 12-month period preceding the
evaluation ranged from 2 to 8 attacks per month. The mean dis-
ease duration was 18.48±9.49 years (range 1–37) [18.85±10.13 in
females and 17±6.70 (range: 10–28) in males]. Patients were not
under preventive medication during the study period.
In all patients anxiety and depression were evaluated using
the Hamilton Anxiety Rating Scale (HAMA) [8], the State and
Trait Anxiety Inventory-State Anxiety (STAY-S) [9] and the Beck
Depression Inventory (BDI) [10] according to Endler et al. [11]
to consider psychological and somatic symptoms of depression
separately. Alexithymia was evaluated by using the 20-item
Toronto Alexithymia Scale (TAS-20) [12]. Psychopathological
evaluation was executed by a specialist that was blind to the
headache diagnoses. Patients were divided into three subgroups
according to pain location (R-SLM, L-SLM and SSM). One-way
ANOVAs were performed to compare scores obtained in the three
groups of patients. Post-hoc analyses with LSD method were also
performed whenever the group effect was significant. Finally,
Spearman’s rho correlations were performed to investigate the
relationship between some demographic and clinical variables
(such as sex, age at observation, age at onset, illness duration and
mean frequency of attacks) and psychopathological features.
Results
Results of one-way ANOVAs and post-hoc analyses are
reported in Table 1. As shown in the table, the L-SLM
group obtained significantly higher scores compared to the
R-SLM group on BDI, HAMA and STAY-S. The L-SLM
group achieved higher scores than the SSM group in cogni-
tive–affective BDI sub-scale scores and STAY-S scores. No
statistically significant results were found between groups
on TAS-20 scores. In the overall group of patients, no sig-
nificant correlations (i.e. all p>0.10) were found with
demographic variables, clinical features of migraine and
psychopathological measures. A significant positive corre-
lation between mean monthly frequency of attacks and
TAS-20 total score (rho=0.68; p=0.032), partial score on F1
subscale of TAS-20 (rho=0.75; p=0.013) and somatic sub-
scale of HAMA (rho=0.69; p=0.020) were found in SSM
patients. In the same group a significant linear correlation
between age at onset of migraine and partial score on F2
subscale of TAS-20 (rho=0.70; p=0.023) was also found.
Discussion
The majority of clinical and population studies [1–3,
13–15] suggest the presence of a close relationship
Table 1 Comparisons between scores obtained by strictly unilateral migraineurs with right side-locked, left side-locked and side-shifting
pain on psychopathological scales
Psychopathological scales L-SLM R-SLM SSM F (2,32) p
BDI-Tot 13.27  1(10.3)**°° 6.92  1(4.32) 7.82  1(6.98) 2.45 n.s
BDI-Cogn 8  1(5.98)*°°* 3.15  1(2.23) 3.91  1(4.86) 3.81 0.033
BDI-Phy 4.82  1(3.21)**** 3.31  1(2.13) 3.64  1(2.06) 1.16 n.s.
STAY-S 42.73  1(7.21)**°° 35.38  1(6.67) 30.73  1(4.49) 10.26 <0.001
HAMA-Tot 10.18  1(5.72)*°°* 4.38  1(4.40) 8.63  1(5.81) 3.90 0.030
HAMA-Psy 7.55  1(4.08)*°°* 3.77  1(3.91) 5.64  1(3.80) 2.75 0.079
HAMA-Som 2.64  1(2.11)*°*° 0.62  1(0.87) 3.00  1(3.63) 3.48 0.043
TAS-20 Tot 49.55 (12.82)°°** 44.54  (13.93) 43.8  (10.26) 0.67 n.s
L-SLM, left side-locked unilateral migraine; R-SLM, right side-locked unilateral migraine; SSM, side-shifting unilateral migraine; n.s., sta-
tistically not significant
*Post-hoc analyses with LSD method indicating a significant difference between L-SLM and R-SLM groups with p<0.05; **Post-hoc
analyses indicating a significant difference between L-SLM and R-SLM groups with p<0.01; °Post-hoc analyses indicating a significant
difference between L-SLM and SSM groups with p<0.05; °°Post-hoc analyses indicating a significant difference between L-SLM and SSM
groups with p<0.01
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between migraine, depression and anxiety disorders.
These studies considered MO and MA both together and
separately, without any specification on the side of the
pain. In a study that attempted to differentiate between the
two migraine subtypes [2], MA patients were found to
have higher rates for major depression (45.5 vs. 31.9%),
dysthymia and manic episodes compared with MO
patients. These findings have been supported by further
studies [13, 14] reporting that anxiety disorders and major
depression co-existed in 30% of migraine patients.
Breslau et al. [1] reviewed the lifetime prevalence rates of
major mood disorders in patients suffering from MA and
MO, underlining that the onset of anxiety generally pre-
cedes onset of migraine, which in turns precedes the onset
of depression. This pattern seems to be the result of a two-
way “bi-directional” relationship between the two condi-
tions, ruling out the possibility that mood disturbances
could be secondary to repeated migraine attacks. These
psychopathological findings in migraine patients appear
to be confirmed by further clinical studies [3, 15]. In the
present study, we investigated the relationship between
pain location and anxiety, depression and alexithymia in
strictly unilateral migraineurs. Alexithymia, substantially
defined by difficulty in identifying and describing own
feelings and by an externally oriented cognitive style [16],
has been previously investigated in headache patients
[17], in particular in those with chronic tension-type
headache [18]. Recent data showed that alexithymia is
more frequent in MO patients compared to healthy sub-
jects [19]. Our data do not show a relationship between
side-locked pain and alexithymia in migraineurs.
However, we cannot make assumptions on the prevalence
of alexithymia in these patients. On the contrary, the
results of the present study evidence that L-SLM patients
are more anxious and depressed than the other two groups.
This finding could be interpreted from a neurobiological
perspective. Indeed, it could be argued that the recurrence
of pain on the left cerebral hemisphere could be likely
related to a hemispheric biochemical dysfunction. As a
matter of fact, proposed pathogenetic hypotheses on
migraine indicated an impaired cerebral metabolism
underlying cortical spreading depression and the related
headache, suggesting an unmasking dysfunction of brain
mitochondria [6]. Furthermore, PET studies during
migraine attacks demonstrated episodic dysfunction of
certain brainstem areas [20]. Our data are consistent with
these reports and with previous studies showing a rela-
tionship between anxiety and depression with vascular left
cerebral lesions [4] and with metabolic alteration in left
frontal regions [5]. Therefore, the correlation between left
unilateral migraine, anxiety and depression we found in
migraineurs offers new clues on the role of left cerebral
hemisphere in these disorders.
Although the absence of a control group of healthy
subjects and the small size of our sample represent an
important limitation of the study, our preliminary data
seem to indicate that the investigation of the relationship
between head pain location and psychopathological alter-
ations in strictly unilateral migraine may be a field of
interest for further research.
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